CD177 and neoplasm: These processes are reminiscent of immune changes observed during tumorigenesis, where tumors upregulate a repertoire of cell surface receptors and adaptive changes in the tumor microenvironment to escape T cell killing and foster immunosuppression and tumor-promoting effects such as angiogenesis.